Abstract: The present invention provides a method of diagnosis or prognosis endometrial carcinoma, the method comprising determining the level of expression of MMP9 in a uterine aspirate fluid sample from the female genital tract. The present invention further provides kits for the diagnosis of the disease.
Type:
Application
Filed:
March 30, 2017
Publication date:
May 9, 2019
Applicants:
FUNDACIÓ HOSPITAL UNIVERSITARI VALL D'H'EBRON-INSTITUT DE RECERCA, LUXEMBOURG INSTITUTE OF HEALTH (LIH), INSTITUT DE RECERCA BIOMÈDICA DE LLEIDA FUNDACIÓ DR. PIFARRÉ
Inventors:
Elena MARTINEZ GARCÍA, Eva COLÁS ORTEGA, Antonio GIL MORENO, Jaume REVENTÓS PUIGJANER, Bruno DOMON, Antoine LESUR